 HAIKOU CITY, China , March 26, 2021 PRNewswire -- China Pharma Holdings, Inc. NYSE American: CPHI China Pharma, the Company or We, an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the fiscal year ended December 31, 20 20 . Full Year Highlights Revenue was both 10.9 million in fiscal year 2020 and 2019 , respectively ; Gross margin was 1 8.0 in fiscal year 20 20 , compared to 1 3.6 in fiscal year 201 9; Loss from operations was 2 .6 million in fiscal year 20 20 compared to 2 0.4 million in fiscal year 201 9 , which represented a n improvement of 17.8 million; Net loss was 2 .9 million in fiscal year 20 20 compared to 20.7 million in fiscal year 201 9. 